Research gaps on methadone harms and comparative harms: findings from a review of the evidence for an American Pain Society and College on Problems of Drug Dependence clinical practice guideline.

[1]  R. Chou,et al.  Systematic evidence review on methadone harms and comparative harms , 2014 .

[2]  R. Chou,et al.  Methadone overdose and cardiac arrhythmia potential: findings from a review of the evidence for an American Pain Society and College on Problems of Drug Dependence clinical practice guideline. , 2014, The journal of pain : official journal of the American Pain Society.

[3]  R. Chou,et al.  Methadone safety: a clinical practice guideline from the American Pain Society and College on Problems of Drug Dependence, in collaboration with the Heart Rhythm Society. , 2014, The journal of pain : official journal of the American Pain Society.

[4]  C. Teljeur,et al.  Risk of drug-related mortality during periods of transition in methadone maintenance treatment: a cohort study. , 2011, Journal of substance abuse treatment.

[5]  P. T. Korthuis,et al.  The Source of Methadone in Overdose Deaths in Western Virginia in 2004 , 2011, Journal of addiction medicine.

[6]  Kimberly D. McCoy,et al.  Comparative mortality among Department of Veterans Affairs patients prescribed methadone or long-acting morphine for chronic pain , 2011, PAIN®.

[7]  J. Strang,et al.  Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation? , 2011, Drug and alcohol review.

[8]  A. Berrebi,et al.  Buprenorphine versus methadone in pregnant opioid-dependent women: a prospective multicenter study , 2011, European Journal of Clinical Pharmacology.

[9]  M. Tegeler,et al.  Morphine to Methadone Conversion: An Interpretation of Published Data , 2011, The American journal of hospice & palliative care.

[10]  H. Jones,et al.  Neonatal abstinence syndrome after methadone or buprenorphine exposure. , 2010, The New England journal of medicine.

[11]  L. Woodward,et al.  Maternal methadone dose during pregnancy and infant clinical outcome. , 2010, Neurotoxicology and teratology.

[12]  E. Bass,et al.  AHRQ series paper 5: grading the strength of a body of evidence when comparing medical interventions--agency for healthcare research and quality and the effective health-care program. , 2010, Journal of clinical epidemiology.

[13]  R. Millman,et al.  Obstructive sleep apnea is more common than central sleep apnea in methadone maintenance patients with subjective sleep complaints. , 2010, Drug and alcohol dependence.

[14]  A. Giglio,et al.  Early switching from morphine to methadone is not improved by acetaminophen in the analgesia of oncologic patients: a prospective, randomized, double-blind, placebo-controlled study , 2010, Supportive Care in Cancer.

[15]  E. Bruera,et al.  The effect of oral methadone on the QTc interval in advanced cancer patients: a prospective pilot study. , 2010, Journal of palliative medicine.

[16]  L. Paulozzi,et al.  A comparison of drug overdose deaths involving methadone and other opioid analgesics in West Virginia. , 2009, Addiction.

[17]  J. Bell,et al.  Comparing overdose mortality associated with methadone and buprenorphine treatment. , 2009, Drug and alcohol dependence.

[18]  T Fahey,et al.  Factors associated with mortality in Scottish patients receiving methadone in primary care: retrospective cohort study , 2009, BMJ : British Medical Journal.

[19]  T. Clausen,et al.  Prevalence and clinical relevance of corrected QT interval prolongation during methadone and buprenorphine treatment: a mortality assessment study. , 2009, Addiction.

[20]  D. Epstein,et al.  Electrocardiographic Effects of Lofexidine and Methadone Coadministration: Secondary Findings from a Safety Study , 2009, Pharmacotherapy.

[21]  H. Mactier,et al.  Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources , 2009, BJOG : an international journal of obstetrics and gynaecology.

[22]  J. Attia,et al.  Hypogonadism in men receiving methadone and buprenorphine maintenance treatment. , 2009, International journal of andrology.

[23]  E. Ravndal,et al.  Opioid Maintenance Treatment during Pregnancy: Occurrence and Severity of Neonatal Abstinence Syndrome , 2009, European Addiction Research.

[24]  M. Gourevitch.  First Do No Harm Reduction? , 2009, Annals of Internal Medicine.

[25]  G. Pasternak,et al.  Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. , 2009, The journal of pain : official journal of the American Pain Society.

[26]  Z. L. Quick,et al.  Acoustic cry characteristics of infants exposed to methadone during pregnancy , 2009, Acta paediatrica.

[27]  R. Grunstein,et al.  Subjective daytime sleepiness and daytime function in patients on stable methadone maintenance treatment: possible mechanisms. , 2008, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

[28]  Leonard J Paulozzi,et al.  Patterns of abuse among unintentional pharmaceutical overdose fatalities. , 2008, JAMA.

[29]  C. Ficorella,et al.  Sustained‐release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management , 2008, European journal of pain.

[30]  M. Krantz.  Heterogeneous Impact of Methadone on the QTc Interval: What Are the Practical Implications? , 2008, Journal of addictive diseases.

[31]  M. Heilig,et al.  Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series. , 2008, Drug and alcohol dependence.

[32]  P. Psaltis,et al.  Electrocardiogram Characteristics of Methadone and Buprenorphine Maintained Subjects , 2008, Journal of addictive diseases.

[33]  B. Grant,et al.  Sleep-disordered breathing and chronic opioid therapy. , 2008, Pain medicine.

[34]  J. Attia,et al.  Erectile dysfunction in men receiving methadone and buprenorphine maintenance treatment. , 2008, The journal of sexual medicine.

[35]  T. Binder,et al.  Prospective randomised comparative study of the effect of buprenorphine, methadone and heroin on the course of pregnancy, birthweight of newborns, early postpartum adaptation and course of the neonatal abstinence syndrome (NAS) in women followed up in the outpatient department. , 2008, Neuro endocrinology letters.

[36]  L. Fingerhut.  Increases in poisoning and methadone-related deaths: United States, 1999-2005 , 2008 .

[37]  G. Bigelow,et al.  QT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized trial. , 2007, Archives of internal medicine.

[38]  Daniel M. Hartung,et al.  Rates of Adverse Events of Long-Acting Opioids in a State Medicaid Program , 2007, The Annals of pharmacotherapy.

[39]  G. Jensen,et al.  Syncope and QT prolongation among patients treated with methadone for heroin dependence in the city of Copenhagen , 2007, Heart.

[40]  M. Kreek,et al.  Corrected-QT intervals as related to methadone dose and serum level in methadone maintenance treatment (MMT) patients: a cross-sectional study. , 2007, Addiction.

[41]  L. Paulozzi,et al.  Opioid analgesics and rates of fatal drug poisoning in the United States. , 2006, American journal of preventive medicine.

[42]  I. Galynker,et al.  Neuropsychological functioning in opiate-dependent subjects receiving and following methadone maintenance treatment. , 2006, Drug and alcohol dependence.

[43]  L. Paulozzi.  Opioid analgesic involvement in drug abuse deaths in American metropolitan areas. , 2006, American journal of public health.

[44]  Yongli Xi,et al.  Increasing deaths from opioid analgesics in the United States , 2006, Pharmacoepidemiology and drug safety.

[45]  A. Gal‐Oz,et al.  Methadone-associated Torsades de Pointes (polymorphic ventricular tachycardia) in opioid-dependent patients. , 2006, Addiction.

[46]  D. Shah,et al.  Drug-induced long QT syndrome in injection drug users receiving methadone: high frequency in hospitalized patients and risk factors. , 2006, Archives of internal medicine.

[47]  L. Simmat-Durand,et al.  Prospective multicenter observational study of 260 infants born to 259 opiate-dependent mothers on methadone or high-dose buprenophine substitution. , 2006, Drug and alcohol dependence.

[48]  R. Hoffman,et al.  Testing positive for methadone and either a tricyclic antidepressant or a benzodiazepine is associated with an accidental overdose death: analysis of medical examiner data. , 2006, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[49]  M. Soyka,et al.  Fatal Poisoning in Methadone and Buprenorphine Treated Patients - Are there Differences? , 2006, Pharmacopsychiatry.

[50]  W. Rayburn,et al.  Effect of Chronic Maternal Methadone Therapy on Intrapartum Fetal Heart Rate Patterns , 2006, The Journal of the Society for Gynecologic Investigation: JSGI.

[51]  H. Aschauer,et al.  Methadone versus buprenorphine in pregnant addicts: a double-blind, double-dummy comparison study. , 2006, Addiction.

[52]  Bridget A. Martell,et al.  Effects of Methadone on QT‐Interval Dispersion , 2005, Pharmacotherapy.

[53]  O. Drummer,et al.  Ventilatory responses to hypoxia and hypercapnia in stable methadone maintenance treatment patients. , 2005, Chest.

[54]  O. Drummer,et al.  Central sleep apnea in stable methadone maintenance treatment patients. , 2005, Chest.

[55]  B. Lester,et al.  Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome. , 2005, Drug and alcohol dependence.

[56]  M. Stitzer,et al.  Opioid abuse and cognitive performance. , 2005, Drug and alcohol dependence.

[57]  Bridget A. Martell,et al.  Impact of methadone treatment on cardiac repolarization and conduction in opioid users. , 2005, The American journal of cardiology.

[58]  R. Portenoy,et al.  Measurement of QTc in patients receiving chronic methadone therapy. , 2005, Journal of pain and symptom management.

[59]  M. Mundt,et al.  Methadone Maintenance and Male Sexual Dysfunction , 2005, Journal of addictive diseases.

[60]  S. Lathrop,et al.  Unintentional methadone-related overdose death in New Mexico (USA) and implications for surveillance, 1998-2002. , 2005, Addiction.

[61]  E. Bruera,et al.  Oral methadone for cancer pain: no indication of Q-T interval prolongation or torsades de pointes. , 2004, Journal of pain and symptom management.

[62]  F. Baud,et al.  A critical review of the causes of death among post-mortem toxicological investigations: analysis of 34 buprenorphine-associated and 35 methadone-associated deaths. , 2004, Addiction.

[63]  T. M. Piper,et al.  Overdose deaths attributed to methadone and heroin in New York City, 1990-1998. , 2004, Addiction.

[64]  Roger Chou,et al.  Comparative efficacy and safety of long-acting oral opioids for chronic non-cancer pain: a systematic review. , 2003, Journal of pain and symptom management.

[65]  J. Gilchrist,et al.  Increase in deaths due to methadone in North Carolina. , 2003, JAMA.

[66]  J. Oliver,et al.  The role of methadone in drug-related deaths in the west of Scotland. , 2003, Addiction.

[67]  P. Mehler,et al.  Dose‐Related Effects of Methadone on QT Prolongation in a Series of Patients with Torsade de Pointes , 2003, Pharmacotherapy.

[68]  F. Apple,et al.  Methadone-related deaths in Hennepin County, Minnesota: 1992-2002. , 2003, Journal of forensic sciences.

[69]  M. Erkens,et al.  Methadone-Related Deaths Associated with Faulty Induction Procedures , 2003 .

[70]  Jason M. White,et al.  Buprenorphine versus methadone maintenance therapy: a randomized double-blind trial with 405 opioid-dependent patients. , 2003, Addiction.

[71]  E. Ernst,et al.  Methadone‐related deaths in Western Australia 1993–99 , 2002, Australian and New Zealand journal of public health.

[72]  W. van den Brink,et al.  An increase in overdose mortality during the first 2 weeks after entering or re-entering methadone treatment in Amsterdam. , 2002, Addiction.

[73]  R. Ehrman,et al.  A randomized, double-blind, placebo-controlled safety study of high-dose dextromethorphan in methadone-maintained male inpatients. , 2002, Drug and alcohol dependence.

[74]  S. Sunjic,et al.  Methadone-related deaths and mortality rate during induction into methadone maintenance, New South Wales, 1996. , 2002, Drug and alcohol review.

[75]  J. Strang,et al.  Effects of methadone on cognition, mood and craving in detoxifying opiate addicts: a dose-response study , 2001, Psychopharmacology.

[76]  Jason M. White,et al.  Hyperalgesic responses in methadone maintenance patients , 2001, Pain.

[77]  M. Stitzer,et al.  A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence. , 2000, The New England journal of medicine.

[78]  S. McDonald,et al.  Cognitive impairment among methadone maintenance patients. , 2000, Addiction.

[79]  T. Finkbeiner,et al.  Cognitive-Motor Performance of Methadone-Maintained Patients , 2000, European Addiction Research.

[80]  J. Neale.  Methadone, methadone treatment and non-fatal overdose. , 2000, Drug and alcohol dependence.

[81]  M. Langendam,et al.  Dose-effect relationship between overdose mortality and prescribed methadone dosage in low-threshold maintenance programs. , 1999, Addictive behaviors.

[82]  J. Fountain,et al.  NIH Consensus Panel Recommends Expanding Access to and Improving Methadone Treatment Programs for Heroin Addiction , 1999, European Addiction Research.

[83]  J. Hughes,et al.  First Do No Harm: Adverse Effects of Grouping Deviant Youth for Skills Training , 1999 .

[84]  H. Aschauer,et al.  Comparison of methadone and slow-release morphine maintenance in pregnant addicts. , 1999, Addiction.

[85]  S. Mercadante,et al.  Morphine versus methadone in the pain treatment of advanced-cancer patients followed up at home. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[86]  P. Zannikos,et al.  The effect of fluconazole on the clinical pharmacokinetics of methadone , 1998, Clinical pharmacology and therapeutics.

[87]  S. Sunjic,et al.  Methadone‐related deaths in New South Wales , 1997, The Medical journal of Australia.

[88]  Jason M. White,et al.  Methadone‐related overdose deaths in South Australia, 1984‐1994: How safe is methadone prescribing? , 1997, The Medical journal of Australia.

[89]  T. S. Jones,et al.  An investigation of medical examiner cases in which methadone was detected, Harris County, Texas, 1987-1992. , 1996, Journal of forensic sciences.

[90]  N. Shaw,et al.  Neonatal abstinence syndrome after maternal methadone treatment. , 1994, Archives of disease in childhood. Fetal and neonatal edition.

[91]  S. Kandall,et al.  Relationship of maternal substance abuse to subsequent sudden infant death syndrome in offspring. , 1993, The Journal of pediatrics.

[92]  L. Öhlund,et al.  Mortality in heroin addiction: impact of methadone treatment , 1990, Acta psychiatrica Scandinavica.

[93]  C. Eastman,et al.  Abnormalities in thyroid function associated with chronic therapy with methadone. , 1988, Clinical chemistry.

[94]  J. Thornton,et al.  Impact of maternal drug dependency on birth weight and head circumference of offspring. , 1987, American journal of diseases of children.

[95]  F. De Conno,et al.  A randomized study on oral administration of morphine and methadone in the treatment of cancer pain. , 1986, Journal of pain and symptom management.

[96]  E. Smith,et al.  Factors affecting head growth and intellectual function in children of drug addicts. , 1985, Pediatrics.

[97]  I. Chasnoff,et al.  Perinatal addiction: the effects of maternal narcotic and nonnarcotic substance abuse on the fetus and neonate. , 1984, NIDA research monograph.

[98]  P. Appel.  Sustained attention in methadone patients. , 1982, The International journal of the addictions.

[99]  I. Chasnoff,et al.  Polydrug- and methadone-addicted newborns: a continuum of impairment? , 1982, Pediatrics.

[100]  M. Barranco,et al.  Doxepin as adjunctive therapy for depressed methadone maintenance patients: a double-blind study. , 1982, The Journal of clinical psychiatry.

[101]  D. Dinges,et al.  Fetal exposure to narcotics: neonatal sleep as a measure of nervous system disturbance. , 1980, Science.

[102]  L. Finnegan,et al.  Perinatal addiction: outcome and management. , 1977, American journal of obstetrics and gynecology.

[103]  R. Harper,et al.  Maternal ingested methadone, body fluid methadone, and the neonatal withdrawal syndrome. , 1977, American journal of obstetrics and gynecology.

[104]  A. Eidelman,et al.  The narcotic-dependent mother: fetal and neonatal consequences. , 1977, Early human development.

[105]  A. Eidelman,et al.  Differential effects of maternal heroin and methadone use on birthweight. , 1976, Pediatrics.

[106]  P. Appel,et al.  Digit-symbol performance in methadone-treated ex-heroin addicts. , 1976, The American journal of psychiatry.

[107]  N. Lenn,et al.  Neurological assessment of patients on prolonged methadone maintenance. , 1976, Drug and alcohol dependence.

[108]  K. Adamsons,et al.  Narcotic dependency in pregnancy. Methadone maintenance compared to use of street drugs. , 1976, JAMA.

[109]  G. Woody,et al.  Depression and anxiety in heroin addicts: a placebo-controlled study of doxepin in combination with methadone. , 1975, The American journal of psychiatry.

[110]  S. Shiffman,et al.  Physiological and psychological effects of methadone in man. , 1975, Archives of general psychiatry.

[111]  R. Newman,et al.  Results of 313 consecutive live births of infants delivered to patients in the New York City Methadone Maintenance Treatment Program. , 1975, American journal of obstetrics and gynecology.

[112]  M. Strauss,et al.  Methadone maintenance during pregnancy: pregnancy, birth, and neonate characteristics. , 1974, American journal of obstetrics and gynecology.

[113]  M. Schweitzer,et al.  An epidemiologic evaluation of long-term methadone maintenance treatment for heroin addiction. , 1974, American journal of epidemiology.

[114]  M. Casalino,et al.  Neonatal narcotic addiction. Comparative effects of maternal intake of heroin and methadone. , 1973, The New England journal of medicine.

[115]  E. Donoso,et al.  The effect of heroin and multiple drug abuse on the electrocardiogram. , 1973, American heart journal.

[116]  P. Cushman.  Plasma testosterone in narcotic addiction. , 1973, The American journal of medicine.

[117]  W. Leblanc,et al.  Methadone withdrawal in newborn infants. , 1972, The Journal of pediatrics.

[118]  A. Pastor,et al.  Prevalence of long QTc interval in methadone maintenance patients. , 2009, Drug and alcohol dependence.

[119]  H. Kalska,et al.  Substance Abuse Treatment, Prevention, and Policy Memory Function in Opioid-dependent Patients Treated with Methadone or Buprenorphine along with Benzodiazepine: Longitudinal Change in Comparison to Healthy Individuals , 2009 .

[120]  K. Reinier,et al.  A community-based evaluation of sudden death associated with therapeutic levels of methadone. , 2008, The American journal of medicine.

[121]  G. Guyatt,et al.  Grading strength of recommendations and quality of evidence in clinical guidelines: report from an american college of chest physicians task force. , 2006, Chest.

[122]  G. Guyatt,et al.  Guidelines: Report From an American College of Chest Physicians Task Force Grading Strength of Recommendations and Quality of Evidence in Clinical , 2006 .

[123]  T. Gunn,et al.  The effect of methadone treatment on the quantity and quality of human fetal movement. , 2004, Neurotoxicology and teratology.

[124]  E. Bruera,et al.  Methadone versus morphine as a first-line strong opioid for cancer pain: a randomized, double-blind study. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[125]  R. Mattick,et al.  Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. , 2003, The Cochrane database of systematic reviews.

[126]  J. Barry,et al.  Opiate-related deaths in Dublin , 2001, Irish journal of medical science.

[127]  S. Sunjic,et al.  Deaths in methadone maintenance treatment in New South Wales, Australia 1990-1995. , 2000, Addiction.

[128]  G. Randolph,et al.  Assessment of fetal well-being in methadone-maintained pregnancies: abnormal nonstress tests. , 1997, Gynecologic and obstetric investigation.

[129]  E. Brizendine,et al.  Methadone maintenance in pregnancy: A reappraisal , 1997 .

[130]  J. Caplehorn,et al.  Methadone maintenance and addicts' risk of fatal heroin overdose. , 1996, Substance use & misuse.

[131]  J. E. West.  First, do no harm. , 1994, Alabama medicine : journal of the Medical Association of the State of Alabama.

[132]  Johnson Hl,et al.  Long-term effects of prenatal methadone maintenance. , 1985 .

[133]  T. Rosen,et al.  Long-term effects of prenatal methadone maintenance. , 1985, NIDA research monograph.

[134]  Pippenger Ce,et al.  Disposition of methadone and its relationship to severity of withdrawal in the newborn. , 1975 .

[135]  C. Pippenger,et al.  Disposition of methadone and its relationship to severity of withdrawal in the newborn. , 1975, Addictive diseases.

[136]  H. Kalska,et al.  Bmc Clinical Pharmacology Methadone vs. Buprenorphine/naloxone during Early Opioid Substitution Treatment: a Naturalistic Comparison of Cognitive Performance Relative to Healthy Controls , 2022 .